日本大学医学部 内科学系 神経内科学分野

研究業績
<2014>
1.Morita A, et al. Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan. J Infect Chemother 20: 535-540, 2014.
2.Ogawa K, et al. Clinical study of the visual field defects caused by occipital lobe lesions. Cerebrovasc Dis 37: 102-108, 2014.
3.Ogawa K, et al. Immunohistochemical study of pseudohypertrophy of the inferior olivary nucleus. Clin Neuropathol 33: 68-75, 2014.
4.Suzuki Y, et al. Ethanol consumption decrease thiamine levels. Int Med J, 2014 (in press).
<2013>
1.Ogawa K, et al. Two patients with isolated dysarthria caused by cerebellar infarction. Cent Eur J Med 8: 725-729, 2013.
2.Suzuki Y, et al. Amyotrophic lateral sclerosis accompanying elevated catecholamines occuring as a complication of takotsubo cardiomyopathy. Geriatr Gerontol Int 13: 240-241, 2013.
3.Suzuki Y, et al. Ethanol consumption increases methanol. Int Med J 20: 285-287,2013.
4.Ogawa K, et al. Clinical study of medial area infarction in the region of posterior inferior cerebellar artery. J Stroke Cerebrovasc Dis 22: 508-513, 2013.
5.Morita A, et al. Relationship between quantitative electroencephalogram and interferon-a-induced depression in chronic hepatitis C patients. Neuropsychobiology 67: 122-126, 2013.
6.Hara M, et al. Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology. Acta Neuropathol 125: 565-579, 2013.
<2012>
1.Hara M, et al. Miller Fisher syndrome associated with influenza A infection. Intern Med 52: 2621-2623, 2012.
2.Morita A, et al. Opsoclonus-myoclonus syndrome following influenza A infection. Intern Med 51: 2429-2431, 2012.
3.Ogawa K, et al. Clinical study of twenty-one patients with pure midbrain infarction. Eur Neurol 67: 81-89, 2012.
4.Suzuki Y, et al. A patient with Marchiafava-Bignami disease as a complication of diabetes mellitus treated effectively with corticosteroid. J Clin Neurosci 19: 761-762, 2012.
5.Suzuki Y, et al. Case of acute cerebellitis as a result of varicella zoster virus infection without skin manifestations. Geriatr Gerontol Int 12: 756-757, 2012.
6.Suzuki Y, et al. Case of beriberi showing improved cerebral blood flow after thiamine treatment. Geriatr Gerontol Int 12: 757-759, 2012.
7.Kanno A, et al. A healthy, 81-year-old woman with toxoplasmic encephalitis. Geriatr Gerontol Int 12: 759-761, 2012.
8.Hara M, et al. Lower motor neuron disease caused by a novel FUS/TLS gene frameshift mutation. J Neurol 259: 2237-2239, 2012.
<2011>
1. Suzuki Y, Oishi M, Ishihara M, Kamei S. A case of Creutzfeldt-Jakob disease showing decreased cerebral blood flow on Tc-99m ECD SPECT at an early stage. Cesk Slov Neurol Neurosurg: 2011 (in press).
2. Ogawa K, Yoshihashi H, Suzuki Y, Oishi M, Kamei S: A case of Creutzfeldt-Jakob disease presenting with complex partial seizure following sleeplessness and cognitive impairment. Geriatr Gerontol Int: 2011(in press).
3.Morita A, Kamei S, Mizutani T: Relationship between slowing of the EEG and cognitive impairment in Parkinson's disease. J Clin Neurophysiol, 2011 (in press).
4.Hara M, Morita A, Kamei S, Yamaguchi M, Homma T, Nemoto N, Sugita K, Yamamoto T, Dalmau J: Anti-N-methyl- d-aspartate receptor encephalitis associated with carcinosarcoma with neuroendocrine differentiation of uterus. J Neurol: 2011 (in press).
5.Yamada T, Sunagawa K, Homma T, Uehara K, Mizutani T, Kawabata Y. Ubiquitin-positive pneumocytes and inclusion bodies are present in secondary organizing pneumonia. Intern Med 50:277-283, 2011.
<2010>
1.Kamei S, Morita A, Serizawa K, Mizutani T, Hirayanagi K: Quantitative EEG analysis of executive dysfunction in Parkinson’s disease. J Clin Neurophysiol 27(3): 193-197, 2010.
2.Suzuki Y, Ogawa K, Shiota H, Kamei S, Oishi M, Mizutani T: Current perception threshold in Subacute Myelo-Optico- Neuropathy. Int J Neurosci120: 368-371, 2010.
3.Suzuki Y, Oishi M, Ogawa K, Mizutani T: Atrophy of the parahippocampal gyrus and regional cerebral blood flow in the limbic system in chronic alcoholic patients. Alcohol 44:439-445, 2010.
4.Suzuki Y, Ogawa K, Oishi M, Mizutani T. Recovery of decreased cerebral blood flow in Wernicke’s encephalopathy following abstinence from Alcohol. Cesk Slov Neurol Neurosurg 73/106: 187-189, 2010.
5.Ogawa K, Suzuki Y, Kamei S: Two patients with abducens nerve palsy and crossed hemiplegia (Raymond syndrome). Acta Neurol Belg 110: 190-192, 2010.
6.Ogawa K, Yoshihashi H, Suzuki Y, Kamei S, Mizutani T: Clinical study of the responsible lesion for dysarthria in the cerebellum. Intern Med 49: 861-864, 2010
7.Ogawa K, Mizutani T, Uehara K, Minami M, Suzuki Y, Uchihara T: Pathological study of pseudohypertrophy of the inferior olivary nucleus. Neuropathology 30(1) :15 -23, 2010.
8.Ogawa K, Yoshihashi H, Suzuki Y, Oishi M, Kamei S: A case of probable Creutzfeldt-Jakob disease presenting with complex partial seizure following sleeplessness and cognitive impairment. Geriatr Gerontol Int 11(2) : 229-232, 2010.
9.Ogawa K, Oishi M, Mizutani T, Maejima S, Mori T: Dural arteriovenous fistula on the convexity presenting with pure acute subdural hematoma. Acta Neurol Belg 110: 190-192, 2010.
10.Yamaguchi M, Nakayama T, Fu Z, Sato N, Soma M, Morita A, Hinohara S, Doba N, Mizutani T. The haplotype of the CACNA1B gene associated with cerebral infarction in a Japanese population. Hereditas 147:313-319, 2010
11.Ichihara K, Uchihara T, Nakamura A, Suzuki Y, Mizutani T. Correspondence regarding: Selective deposition of 4-repeat Tau in cerebral infarcts. J Neuropathol Exp Neurol 69: 321-321; 2010.
12.Hara M, Kimura J, Walker DD, Taniguchi S, Ichikawa H, Fujisawa R, Shimizu H, Abe T, Yamada T, Kayamori R. Effect of motor imagery and voluntary muscle contraction on the F wave. Muscle Nerve 42: 208-212, 2010
13.Katsuyama N, Yamashita A, Sawada K, Naganuma T, Sakata H, Taira M. Functional and histological properties of caudal intraparietal area of macaque monkey. Neuroscience 167:1-10, 2010.
14.Otaka T, Oshima H, Katayama Y, Kano T, Kobayashi K, Suzuki Y, Fukaya C, Yamamoto T: Impact of subthalamic nucleus stimulation on young-onset Parkinson's disease. Neruomodulation 13: 10-16, 2010.
<2009>
1.Kamei S, Kuzuhara S, Ishihara M, Morita A, Taira N, Togo M, Matsui M, Ogawa M, Hisanaga K, Mizutani T, Kuno S: Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan-Relationship to anti-N-methyl-d-aspartate receptor encephalitis-. Intern Med 48, 673-679, 2009.
2.Kamei S, Taira N, Ishihara M, Sekizawa T, Morita A, Miki K, Shiota H, Kanno A, Suzuki Y, Mizutani T, Itoyama Y, Morishima T, Hirayanagi K: Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 46, 187-193, 2009
3.Kamei S, Morita A, Tanaka N, Matsuura M, Moriyama M, Kojima T, Arakawa Y, Matsukawa Y, Mizutani T, Sakai T, Oga K, Ohkubo H, Matsumura H, Hirayanagi K: Relationships between quantitative-electroencephalographic alterations and severity of hepatitis C based on liver biopsy in interferon-α treated patients. Intern Med 48, 975-980, 2009.
4.Ogawa K, Ishikawa H, Tamura M, Kamei S, Mizutani T: Bilateral superior altitudinal hemianopsia due to bilateral occipital lobe infarction. Neuro-Opthalmology 33: 264-267, 2009.
5.Morita A, Kamei S, Serizawa K, Mizutani T: The relationship between slowing EEGs and the progression of Parkinson’s disease. J Clini Neurophysiol 26: 426-429, 2009
6.Ichihara K, Uchihara T, Nakamura A, Suzuki Y, Mizutani T. Selective deposition of 4-repeat Tau in cerebral infarcts. J Neuropathol Exp Neurol 68; 1029-1036, 2009.
7.Taira N, Kamei S, Morita A, Ishihara M, Miki K, Shiota H, Mizutani T: Predictors of prolonged clinical course in adult patients with herpes simplex virus encephalitis. Intern Med 48:89-94 2009.
8.Ishihara M, Kamei S, Taira N, Morita A, Miki K, Naganuma T, Minami M, Shiota H, Hara M, Mizutani T: Hospital-based study of prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan. Intern Med 48, 295-300, 2009.
9.Yamaguchi M, Nakayama T, Fu Z, Naganuma T, Sato N, Soma M, Doba N, Hinohara S, Morita A, Mizutani T. Relationship between haplotypes of KCNN4 gene and susceptibility to human vascular diseases in Japanese. Med Sci Monit 15: 389-397, 2009
10.Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, Utsumi H, Hatano T, Hattori N, Matsumura M, TakahashiK, Nogawa S, Watanabe Y, Miyamoto T, Miyamoto M, Hirata K: Fatigue in Japanese patients with Parkinson’s disease: A study using Parkinson Fatigue Scale. Movement Disord 24(13): 1977-1983, 2009.
11.Suzuki K, Miyamoto M, Miyamoto T, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K: Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. Parkinsonism Relat D 15, 15-19, 2009.
12. Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M, Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. New Engl J Med 360: 1729-1739, 2009.
13.Ichikawa H, Kimura J, Taniguchi S, Hara M, Fujisawa R, Shimizu H, Yamada T, Kawamura M. Motor imagery facilitates the spinal motor neurons without hemispheric asymmetry. J Clin Neurophysiol 26:358-365, 2009.
14.Ichikawa H, Yamada T, Taniguchi S, Hara M, Fujisawa R, Shimizu H, Kimura J. Changes of recovery function in median nerve somatosensory evoked potentials from awake to sleep. J Clin Neurophysiol 26:183-191, 2009.
15.Yamada T, Satoh S, Sueyoshi S, Mitsumata M, Matsumoto T, Ueno T, Uehara K, Mizutani T. Ubiquitin-positive foam cells are identified in the aortic and mitral valves with atherosclerotic involvement. J Atheroscler Thromb 16:472-479, 2009.
<2008>
1.Kamei S, Hara M, Serizawa K, Murakami M, Mizutani T, Ishiburo M, Kawahara R, Takagi Y, Ogawa K, Yoshihashi H, Shinbo S, Suzuki Y, Yamaguchi M, Morita A, Takeshita J, Hirayanagi K: Executive dysfunction using Behavioural Assessment of the Dysexecutive Syndrome in Parkinson’s dsisease. Movement Disord 23(4), 566-573, 2008.
2.Oishi M, Miki K, Morita A, Fujioka K, Aoki S, Nishino I, Nonaka I, Goto Y, Mizutani T. Mitochondrial encephalomyopathy associated with diabetes mellitus, cataract, and corpus callosum atrophy. Intern Med 2008; 47: 441-444
3.Serizawa K, Kamei S, Morita A, Hara M, Mizutani T, Yoshihashi H, Yamaguchi M, Takeshita J, Hirayanagi K: Comparison of quantitative EEGs between Parkinson’s disease and age-adjusted normal controls. J Clin Neurophysiol 25 (6), 361-366, 2008.
4.Shimodaira M, Nakayama T, Sato N, Saito K, Morita A, Sato I, Takahashi T, Soma M, Izumi Y. Association study of aromatase gene (CYP19A1) in essential hypertension. Int J Med Sci 5: 29-35, 2008.
5.Taniguchi S, Kimura J, Yamada T, Ichikawa H, Hara M, Fujisawa R, Shimizu H, Tani T. Effect of motion imagery to counter rest-induced suppression of F-wave as a measure of anterior horn cell excitability. Clin Neurophysiol. 119: 1346-1352, 2008.
6.Takahashi T, Tamura M, Asami Y, Kitamura E, Saito K, Suzuki T, Takahashi SN, Matsumoto K, Sawada S, Yokoyama E, Takasu T. Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: development and methodology. J Clin Microbiol 46:1708-1715, 2008.
7.Takahashi T, Tamura M, Asami Y, Kitamura E, Saito K, Suzuki T, Takahashi SN, Matsumoto K, Sawada S, Yokoyama E, Takasu T. Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis. J Clin Microbiol 46:1698-1707, 2008.
8.Matsukawa Y, Kamei S, Takahashi S, Kojima T, Nagashima M, Matsuura M, Sawada S: Eye movement and random number in NP lupus evaluation. Clin Rhematol 27: 237-240, 2008.
9.Suzuki K, Miyamoto T, Miyamoto M, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K: Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease. J Neurol Sci 271 (1-2), 47-52, 2008.
10.Oshima H, Katayama Y, Fukaya C, Kano T, Kobayashi K, Yamamoto T, Suzuki Y: Direct inhibition of levodopa-induced beginning-of-dose motor deterioration by subthalamic nucleus stimulation in a patient with Parkinson disease. J Neurosurg 108: 160-163, 2008.
11.Ichiyama T, Matsushige T, Siba P, Suarkia D, Takasu T, Miki K, Furukawa S. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis. J Infect56:376-380, 2008.
12.Yamada T, Uehara K, Mizutani T, Sunagawa K, Sugita Y, Hoshi E, Kawabata Y. Ubiquitin-positive pneumocytes are present in non-specific interstitial pneumonia with immunohistochemical analyses. Histopathology 53:742-744, 2008.
<2007>
1.Morita A, Nakayama T, Soma M, Mizutani T. Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am J Hypertens 20: 527-532, 2007.
2.Morita A, Nakayama T, Doba N, Hinohara S, Mizutani T, Soma M. Genotyping of triallelic SNPs using TaqMan((R)) PCR. Mol Cell Probes 21: 171-176, 2007.
3.Suzuki K, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Hashimoto S, Miyamoto T, Miyamoto M, Hirata K: Characteristics of sleep disturbances in Japanese patients with Parkinson’s disease. A study using Parkinson’s Disease Sleep Scale. Movement Disord 22 (9), 1245-1251, 2007.
4.Hui P, Nakayama T, Morita A, Sato N, Hishiki M, Saito K, Yoshikawa Y, Tamura M, Sato I, Takahashi T, Soma M, Izumi Y, Ozawa Y, Cheng Z. Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res 30: 585-592, 2007.
5.Yoshikawa Y, Nakayama T, Saito K, Hui P, Morita A, Sato N, Takahashi T, Tamura M, Sato I, Aoi N, Doba N, Hinohara S, Soma M, Usami R. Haplotype-based case-control study of the association between the guanylate cyclase activator 2B (GUCA2B, Uroguanylin) gene and essential hypertension. Hypertens Res 30: 789-796, 2007.
6.Ichiyama T, Siba P, Suarkia D, Takasu T, Miki K, Kira R, Kusuhara K, Hara T, Toyama J, Furukawa S. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis. J Neurol Sci 252:45-48, 2007.
7.Shibata N, Kawaguchi M, Uchida K, Kakita A, Takahashi H, Nakano R, Fujimura H, Sakoda S, Ihara Y, Nobukuni K, Takehisa Y, Kuroda S, Kokubo Y, Kuzuhara S, Honma T, Mochizuki Y, Mizutani T, Yamada S, Toi S, Sasaki S, Iwata M, Hirano A, Yamamoto T, Kato Y, Sawada T, Kobayashi M. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model. Neuropathology 27:49-61, 2007.
<2006>
1.Ono S, Nishijo Y, Oishi M, Mizutani T: Comparison of the utility of sympathetic skin response and current perception threshold examinations with conventional examinations for the early electrophysiological diagnosis of diabetic polyneuropathy. Electromyography and Clinical Neurophysiology 46 : 401-407, 2006.
2.Tsuda H, Ishikawa H, Koga N, Ishikawa H, Miki K, Mizutani T. Magnetic resonance imaging findings in divergence paralysis. Neuro-Ophthalmology 30: 59-62, 2006.
3.Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 19: 593-600, 2006.
4.Morita A, Nakayama T, Doba N, Hinohara S, Soma M. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 29: 323-331, 2006.
5.Matsukawa Y, Nagashima M, Kamei S, Tanabe E, Takahashi S, Kojima T, Taira M, Morita K, Matsuuuraa M, Sawada S: Random number generation evaluation in patient with systemic lupus erythmatosus indicates a heterogeneous nature of central nervous system vulnerability. Scand J Rheumatol 35(4),295-299,2006.
6.Kaneko Y, Nakayama T, Saito K, Morita A, Sato I, Maruyama A, Soma M, Takahashi T, Sato N. Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarction. Hypertens Res 29: 665-671, 2006.
7.Saito K, Nakayama T, Sato N, Morita A, Takahashi T, Soma M, Usami R. Haplotypes of the plasminogen activator gene associated with ischemic stroke. Thromb Haemost 96: 331-336, 2006.
8.Ichiyama T, Siba P, Suarkia D, Reeder J, Takasu T, Miki K, Maeba S, Furukawa S. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Cytokine 33:17-20, 2006.
9.Komase K, Nakayama T, Iijima M, Miki K, Kawanishi R, Uejima H. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Vaccine 24:826-834, 2006.
10.Yamada T, Uehara K, Kawanishi R, Mizutani T, Sunagawa K, Araya J, Kawabata Y. Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage. Histopathology 48:846-854, 2006.
<2005>
1.Kamei S, Oga K, Matsuura M, Tanaka N, Kojima T, Arakawa Y, Matsukawa Y, Mizutani T, Sakai T, Ohkubo H, Matsumura H, Moriyama M, Hirayanagi K: Correlation between quantitative-EEG alterations and age of IFN-? treated hepatitis C patients. J Clin Neurophysiol 22(1), 49-52, 2005.
2.Kamei S, Sekizawa H, Shiota H, Mizutani T, Itoyama Y, Takasu T, Morishima T, Hirayanagi K: Evaluation of combination therapy using both aciclovir and corticosteroid in adult patients with herpes simplex encephalitis. J Neurol Neurosurg Pyschiatry 76, 1544-1549, 2005.
3.Naganuma T, Nose I, Inoue K, Takemoto A, Katsuyama N, Taira M. Information processing of geometrical features of a surface based on binocular disparity cues: an fMRI study. Neurosci Res 51:147-155, 2005.
4.Takahashi T, Nakayama T, Tamura M, Ogawa K, Tsuda H, Morita A, Hara M, Togo M, Shiota H, Suzuki Y, Minami M, Ishikawa H, Miki K, Shikata E, Takahashi S, Kuragano T, Matsumoto K, Sawada S, Mizutani T. Nested polymerase chain reaction for assessing the clinical course of tuberculous meningitis. Neurology 64: 1789-1793, 2005.
5.Tsuda H, Ishikawa H, Koshinaga M, Tamura M, Mizutani T. Homonymous hemianopia due to cerebral infarction of the lateral geniculate body. Neuro-Ophthalmology 29:43-47, 2005.
6.Tsuda H, Ishikawa H, Asayama K, Saito T, Endo S, Mizutani T. Abducens nerve palsy and Horner syndrome due to metastatic tumor in the cavernous sinus. Intern Med 44:644-646, 2005.
7.Tsuda H, Ishikawa H, Majima T, Sawada U, Mizutani T. Isolated oculomotor nerve palsy in Churg-Strauss syndrome. Intern Med 44:638-640, 2005.
<2004>
1.Kamei S, Takasu T, Morishima T, Mizutani T: Serial changes of intrathecal viral loads evaluated by chemiluminescence assay and nested PCR with aciclovir treatment in herpes simplex virus encephalitis. Intern Med 43(9), 796-801, 2004.
2.Ishikawa H, Sugie K, Murayama K, Awaya A, Suzuki Y, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 62:620-623, 2004.
3.Konagaya M, Matsumoto A, Takase S, Mizutani T, Sobue G, Konishi T, Hayabara T, Iwashita H, Ujihira T, Miyata K, Matsuoka Y. Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban. J Neurol Sci 218:85-90, 2004.
<2003>
1.Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, Namae H, Saito Y, Kokubun Y, Nishimura T, Kawanishi R, Mizutani T, Markus TJ, Kono J, Asuo PG, Alpers MP. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the eastern highlands of Papua New Guinea. Epidemiol Infect 131:887-898, 2003.
2.Minami M, Mizutani T, Kawanishi R, Suzuki Y, Mori H. Neuronal expression of alpha B crystallin in cerebral infarction. Acta Neuropathologica 105: 549-554, 2003.
3.Ishikawa H, Nonaka I, Nishino I. Negative result in search for human alpha-dystrobrevin deficiency. Muscle Nerve 28:387-388, 2003.
4.Kawanishi R, Mizutani T, Yamada H, Minami M, Kakimi S, Yamada T, Hatori T, Akima M. Ubiquitin-positive inclusions in ependymal cells. Acta Neuropathol 106:129-136, 2003.
5.Mochizuki Y, Mizutani T, Tajiri N, Oinuma T, Nemoto N, Kakimi S, Kitamoto T: Creutzfeldt-Jakob disease with florid plaques after cadaveric dura mater graft. Neuropathology 23: 136-140, 2003
6.Mgone CS, Mgone JM, Takasu T, Miki K, Kawanishi R, Asuo PG, Kono J, Komase K, Alpers MP. Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea. Trop Med Int Health 8:219-227, 2003.
<2002>
1.Kamei S, Sakai T, Matsuura M, Tanaka N, Kojima T, Arakawa Y, Matsukawa Y, Mizutani T, Oga K, Ohkubo H, Matsumura H, Hirayanagi K: Alterations of quantitative-EEG and Mini-Mental State Examination in interferon-α-treated hepatitis C. Eur Neurol 48(2), 102-107, 2002.
2.Oishi M, Mochizuki Y, Suzuki Y, Ogawa K, Naganuma T, Nishio Y, Mizutani T: Current perception threshold and sympathetic skin response in diabetic and alcoholic polyneuropathies. Intern Med 41: 819-822, 2002.
3.Miki K, Komase K, Mgone CS, Kawanishi R, Iijima M, Mgone JM, Asuo PG, Alpers MP, Takasu T, Mizutani T. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. J Med Virol 68:105-112, 2002.
4.Suzuki Y, Oishi M, Mizutani T, Sato Y: Regional Cerebral Blood Flow Measured by the Resting and Vascular Reserve(RVR)Method in Chronic Alcoholics. Alchoholism:Clinical and experimental Research 26: 260-264, 2002
5.Cherian MG, Suzuki Y, Apostolova MD: Mouse astrocyte cultures used to study antioxidant property of metallothionein isoforms. Methods Enzymol 348: 337-342, 2002.
6.Tsutsui KI, Sakata H, Naganuma T, Taira M. Neural correlates for perception of 3D surface orientation from texture gradient. Science. 298:409-412, 2002.
<2001>
1.Mochizuki Y, Oishi M, Mizutani T: Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarction. Journal of Stroke and Cerebrovascular Diseases 10:63-69, 2001.
2.Mochizuki Y, Oishi M, Takasu T: Correlation between P300 components and regional cerebral blood flows. J Clin Neurosci 8: 407-410, 2001
3.Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Ogawa K, Mizutani T: Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J Neurosurg 95: 213?221, 2001.
4.Kosel S, Grasbon-Frodl EM, Arima K, Chimelli L, Hahn M, Hashizume Y, Hulette C, Ikeda K, Jacobsen PF, Jones M, Kobayashi M, Love S, Mizutani T, Rosemberg S, Sasaki A, Smith TW, Takahashi H, Vortmeyer AO, Graeber MB. Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents. Neurogenetics 3:163-170, 2001.
<2000>
1.Kamei S, Takasu T: Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese in-patients. Intern Med 39(11), 894-900, 2000.
2.Suzuki Y, Cherian MG: Effect of ethanol on brain metallothionein in transgenic mice. Alcohol Clin Exp Res 24: 315-322, 2000.
3.Suzuki Y, Apostolova MD, Cherian MG: Astrocyte cultures from transgenic mice to study the role of metallothioneinin cytotoxicityof tert-butyl hydroperoxide. Toxicology 145: 51-62, 2000.
4.Mochizuki Y, Oishi M, Takasu T: Effects of bunazosin hydrochloride sustained-release formulation on cerebral infarction. Int Angiol 19 : 35-38, 2000.
5.Shikata E, Mizutani T, Kokubun Y, Takasu T. 'Iatrogenic' Wernicke's encephalopathy in Japan. Eur Neurol 44:156-161, 2000.
6.Matsukawa Y, Nishinarita S, Horie T, Moriyama M, Tanaka N, Arakawa Y, Kamei S, Matsuura M, Kojima T: Serum concentration of inferferon-?: A comparison between once-a-day and twice-a-day administration. International Journal of Clinical Pharmacology Research 20 (1/2), 17-19, 2000.
7.Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, Hirai S, Ueda K. NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathol 100:115-121, 2000.